Biotechnology Law Report

Executive Editor: Christopher M. Holman, PhD, JD

ISSN: 0730-031X | Online ISSN: 1557-8704 | Published Bimonthly | Current Volume: 41

Impact Factor: 0.318* *2021 Journal Citation Reports™ (Clarivate, 2022)

CiteScore™: 0.2

Delivering critical, authoritative analysis of biotech patents and litigation, regulatory and legislative activity, and trade-related aspects of biotechnology.

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts View Submission Instructions Share with a Colleague

Announcements

Special Collection on Bioterrorism Research
Stay ahead of this fast-moving field of research by accessing our most relevant papers on the topic of bioterrorism. Available for a limited time, access our collection of relevant and recently-published papers from some of our most prominent titles including Applied Biosafety, Biotechnology Law Report, Foodborne Pathogens and Disease, Health Security, and OMICS: A Journal of Integrative Biology. We are pleased to share this research with you through September 30, 2022.
Award Winner

Mary Ann Liebert, Inc., in partnership with the Rosalind Franklin Society has launched a prestigious annual award to recognize outstanding published peer-reviewed research by women and underrepresented minorities in science in each of the publisher’s peer-reviewed journals. The RFS / MAL Award in Science for Biotechnology Law Report has selected Ping-Hsun Chen, JD who authored Taiwan's Efforts to Recreate Remdesivir.

View RFS Awards in Science Book

Featured Content

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.